Avner Halperin

Avner Halperin is an entrepreneur, executive and researcher in the fields of digital health and technology policy. He serves as CEO of Sheba Impact – the commercialization and entrepreneurship arm of Sheba Medical Center - and Deputy Director of ARC Innovation Center at Sheba. In this position, he leads the creation of dozens of breakthrough medical technology startups and the building of a vibrant startup ecosystem around Sheba. In addition, he is Chairman of the Board at EyeControl Ltd. - an AI based medical device company that won the Genesis Award for contribution to the battle again COVID-19.

Previously, he was the founding CEO of EarlySense, a medical technology startup that developed a contactless sensor that became the standard of care in well over 1,000 US hospitals. Earlier, he was VP Marketing at Radcom (NASDAQ: RDCM) and R&D leader at Eldat (acquired by Pricer (PRIC.ST)). He started his career as head of an R&D department in the Intelligence Corps of the IDF.

Avner earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from MIT. He is a Research Fellow at Harvard Kennedy School and a lecturer at Tel Aviv University. In 2019, he gave a TED talk on AI in Healthcare. He is also an inventor with 34 US Patents.